Exhibit 99.1

EXHIBIT 99.1 - JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock, par value $0.01 per share, of Indaptus Therapeutics, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

		Sino Lion Ventures Ltd
	Signature:	/s/ Chenhao Xu
	Name/Title:	Chenhao Xu / Authorized Signatory
	Date:	June 26, 2026

	Signature:	/s/ Chenhao Xu
	Name:	Chenhao Xu
	Date:	June 26, 2026

Indaptus Therapeutics, Inc. SCHEDULE 13D/A